Clinical Trials Sponsored by EOC Pharma

Total 8314 results

Taizhou EOC Pharma Co., Ltd.

Completed

Entinostat in Chinese Postmenopausal Women Patients With Locally Recurrent or Metastatic Breast Cancer

Breast Cancer

China
Taizhou EOC Pharma Co., Ltd.

Not yet recruiting

HR Positive, HER2 Negative Advanced Breast Cancer With Progression After Endocrine Therapy

Solid Tumor, Adult
Taizhou EOC Pharma Co., Ltd.

Completed

Phase I Study of EOC202 Plus Paclitaxel in Chinese Patients With Metastatic Breast Cancer

Solid Tumor, Adult

China
Taizhou EOC Pharma Co., Ltd.

Unknown

Study of EOC317 in Chinese Patients With Advanced Solid Tumors

Solid Tumor

China
Taizhou EOC Pharma Co., Ltd.

Active, not recruiting

Ph3 Study of Exemestane With or Without Entinostat in Chinese Patients With Hormone Receptor-Positive, Locally Advanced or Metastatic Breast Cancer

Advanced Breast Cancer

China
Andrew Hendifar, MD
EOC Pharma

Active, not recruiting

Safety and Efficacy of Telatinib in Combination With Keytruda in Subjects With Advanced Stomach and Gastroesophageal Junction Cancers or Hepatocellular Carcinoma

Hepatocellular Carcinoma | Gastric Cancer

United States
Taizhou EOC Pharma Co., Ltd.
Fountain Medical Development Co., Ltd.

Completed

Telatinib Safety and Pharmacokinetics Study in China Patients With Advanced Solid Tumors

Solid Tumor, Adult

China
Peking Union Medical College Hospital
Taizhou EOC Pharma Co., Ltd.

Unknown

A Randomized Controlled Trial of HER-2 Positive Breast Cancer Patients Treated With Lapatinib vs Herceptin

HER2-positive Breast Cancer

China
Taizhou EOC Pharma Co., Ltd.
Shanghai Zhongshan Hospital; Shanghai East Hospital

Unknown

Telatinib in Combination With Capecitabine/ Oxaliplatin in 1st Line Gastric or GEJ Cancer

Gastric Cancer

China
SEPAR- EPOC

Recruiting

Screening for Lung Health by a Mobile Device (SMILE)

Lung Diseases | COPD

Spain
Azienda Ospedaliero-Universitaria di Parma
DOC generici srl

Completed

Efficacy and Tolerability of the Nutraceutical Formulation Coleosoma in Dyslipidemic Subjects (Coleosoma)

Dyslipidemias

Italy
Xoc Pharmaceuticals

Active, not recruiting

Single Ascending Dose Study to Investigate the Safety and Pharmacokinetics of XC101-D13H in Healthy Adult Subjects

Migraine

United States
Eco Fusion

Unknown

Stress Management Using an App to Improve Response With PDE5 Inhibitors in Men With Erectile Dysfunction.

Erectile Dysfunction

United States
Eco Fusion

Unknown

Mobile Phone-based Intervention for Promoting Healthy Habits and Weight Loss

Hypertension | Diabetes | Overweight | Obese | Weight | Pre-diabetes | Adherence

United States
EOM Pharmaceuticals

Recruiting

A Proof-of-Concept Study Evaluating EOM613 in COVID-19 Infected Patients With Severe Symptoms

COVID-19 Pneumonia | COVID-19 Respiratory Infection | COVID-19 Acute Respiratory Distress Syndrome

Brazil
ROC Foundation

Completed

Effect of ZILRETTA Versus CELESTONE on Quality of Life, Pain, Neuromuscular Function, and Physical Performance

Osteoarthritis, Knee

United States
Koc University Hospital

Completed

Effect of a Compassion Fatigue Resiliency Program

Compassion Fatigue
Koc University Hospital

Recruiting

Transversalis Fascia Plane Block and Rectus Sheath Block in Renal Transplantation Donors

Postoperative Pain

Turkey
Koc University Hospital

Completed

Erector Spinae Plane Block in Renal Transplantation Donors

Erector Spinae Plane Block | Renal Transplantation | Laparoscopic Nephrectomy

Turkey
Koc University Hospital

Completed

Effects of Regional Anesthesia Following Mastectomy

Postoperative Pain
Xoc Pharmaceuticals
Celerion

Active, not recruiting

Single Ascending Dose Study Investigating the Safety, Tolerability, and PK of XC130-A10H in Healthy Adult Subjects

Parkinson's Disease

United States
Koc University Hospital

Unknown

Long-term Follow-up Findings of Inpatients for COVID-19 Pneumonia

Covid19

Turkey
R-Pharm
Covance; Cromos Pharma LLC

Withdrawn

Study of the Efficacy and Safety of a Single Administration of Olokizumab vs. Placebo in Addition to Standard Treatment in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (COVID-19).

COVID-19
POC Medical Systems, Inc.

Unknown

Performance of MammoAlert™, Point of Care System, for the Screening of Breast Cancer in Women 18 Years of Age or Older

Breast Cancer

India
UCB BIOSCIENCES, Inc.
R-Pharm

Terminated

Open-label Study to Assess the Safety and Efficacy of CDP6038 (Olokizumab) in Patients Who Completed RA0056

Rheumatoid Arthritis

United States, Belgium, United Kingdom
AJU Pharm Co., Ltd.
OM Pharma SA

Recruiting

The Efficacy and Safety of OM-89 in Patients With Recurrent Chronic Prostatitis/Chronic Pelvic Pain Syndrome

Chronic Prostatitis With Chronic Pelvic Pain Syndrome | Chronic Prostatitis | Chronic Pelvic Pain Syndrome

Korea, Republic of
UCB BIOSCIENCES, Inc.
R-Pharm

Terminated

The Long-term Safety and Efficacy of CDP6038 (Olokizumab) With Active Rheumatoid Arthritis

Rheumatoid Arthritis

Japan, Korea, Republic of, Taiwan
Yuria-Pharm
Pharmaxi LLC

Completed

Epidemiological Study of the COVID-2019 in Participating Organizations.

Covid19

Ukraine
Columbia University
EOS imaging Inc.

Unknown

Value of 3D Modeling in Spine Surgery

Scoliosis

United States
Zonguldak Bulent Ecevit University
Zeynep Koc

Recruiting

Effect of ANI on Intraoperative Opioid Consumption

Pain | Analgesia | Nociceptive Pain | Nerve Block

Turkey
Glo Science, Inc.
EEC Institute, Inc.

Completed

Evaluating the Efficacy of a Gum Health Formulation on Teeth Whitening in Patients With Gingivitis and Periodontitis

Periodontal Diseases | Tooth Discoloration

United States
University Hospital, Bordeaux
EOS imaging Inc.

Completed

Postural Balance of the Adult (POSTURADULT)

Postural Balance

France
University Hospital, Bordeaux
Grant Agreement ERC SMHEART

Not yet recruiting

Validation of Multi-contrast, High-resolution Cardiac Magnetic Resonance Imaging (CARDIO-IRM)

Cardiac Disease

France
Children's Hospital of Philadelphia
EOS imaging Inc.

Completed

Adolescent Idiopathic Scoliosis (AIS) Patient Positioning in EOS System®

Adolescent Idiopathic Scoliosis

United States
PT Sydna Farma
PT Pharma Metric Labs

Completed

Bioequivalence Study of Cyproterone Acetate and Ethinyl Estradiol in Healthy Female Volunteers

Drug Use

Indonesia
Monash University
Caring Pharmacy; Bionime Corporation; Tigas Pharma

Active, not recruiting

Prevention and Treatment of Diabetes in Adults

PreDiabetes

Malaysia
Istanbul University - Cerrahpasa (IUC)
Koc University Hospital

Completed

The Effect of Breathing Exercise on Chemotherapy-induced Nausea and Vomiting in With Autologous Hematopoietic Stem Cell Transplantation Patients

Chemotherapy-induced Nausea and Vomiting

Turkey
German Resuscitation Registry
European Resuscitation Council (ERC)

Completed

A Multi-centre Survey of Epidemiology, Treatment and Outcome of Patients Suffering an Out-of-hospital Cardiac Arrest (EuReCaONE)

Out of Hospital Cardiac Arrest

Germany
First OC Dermatology

Unknown

Brodalumab in Palmoplantar Psoriasis

Palmoplantar Psoriasis
UCB Biopharma S.P.R.L.
Pharm Research Associates (UK) Ltd.

Completed

Study to Look at How Effective Briviact is as add-on Treatment for Patients With Epilepsy With Partial Onset Seizures (BASE)

Epilepsy With POS With or Without Secondary Generalization

Denmark, Germany, Hungary, Ireland, Italy, Netherlands, Norway, Spain, United Kingdom
UCB Pharma SA

Completed

Open-label Long-term Study of Adjunctive Brivaracetam in Pediatric Subjects With Epilepsy

Epilepsy

United States, Belgium, Czechia, France, Germany, Hungary, Ireland, Italy, Mexico, Poland, Spain, United Kingdom
UCB Pharma SA

Completed

Study With Subjects 18-65 Years Old With Partial Onset Seizures Who Are Currently Taking Levetiracetam

Epilepsy, Partial

Canada, United States
Vifor Pharma, Inc.

Terminated

Pharmacodynamic & Safety of Patiromer in Children & Adolescents (2-<18 Yrs) With Chronic Kidney Disease and Hyperkalemia (EMERALD)

Hyperkalemia

United States, Bulgaria, Canada, Georgia, Germany, Poland, Ukraine
UCB Pharma SA

Completed

Double-blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures

Epilepsy

Belgium, Finland, France, Germany, Hungary, India, Italy, Netherlands, Poland, Spain, Switzerland, United Kingdom
UCB Pharma SA

Completed

Long Term Follow up Treatment With Levetiracetam in Subjects of 4 Years and Older With Generalized Epilepsy

Generalized Epilepsy
UCB Pharma SA

Completed

Prevention of Asthma With Levocetirizine 18 Month Treatment in Infants (12 - 24 Months) Suffering From Eczema (Atopic Dermatitis) and Sensitized to Grass Pollen and/or House Dust Mite (HDM)

Dermatitis, Atopic
UCB Pharma SA

Completed

A follow-on Safety Study of CDP870 in Subjects With Crohn's Disease (CD) Who Have Completed a 26-week Double Blind Study CDP870-031 [NCT00152490] or CDP870-032 [NCT00152425] (PRECiSE 3)

Crohn's Disease

United States, Australia, Austria, Belarus, Belgium, Bulgaria, Czechia, Denmark, Estonia, Germany, Hungary, Israel, Italy, New Zealand, Norway, Poland, Russian Federation, Serbia, Singapore, Slovenia, South Africa, Spain, Ukraine, Canada and more
NicOx
Theradis pharma; Iris Pharma

Withdrawn

Efficacy and Safety of Iota-Carrageenan Eye Drops (NCX-4240) (Goldeneye)

Adenoviral Conjunctivitis

Spain
UCB Pharma GmbH

Completed

Study Evaluating Changes in Total Drug Load and Seizure Frequency Using Vimpat® (Lacosamide) in Combination Therapy (VICTOS)

Focal Epilepsy With and Without Secondary Generalization

Germany, Austria
UCB Pharma SA

Completed

Brivaracetam as add-on Treatment of Unverricht-Lundborg Disease in Adolescents and Adults

Unverricht-Lundborg Disease

France, Italy, Sweden, Finland, Netherlands, Tunisia, Réunion

Clinical Trials Sponsored by EOC Pharma

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Israel

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations